You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
A Phase I, 2-Part, Open-Label, Pharmacokinetic and Drug-Drug Interaction Study of CAZ104 (Avibactam and Ceftazidime in Healthy Subjects)
- Disease
- pharmacokinetics
- Drug Name
- CAZ-104
- Generic Name
- CAZ104
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Sep 7, 2011
- Study Name
- D4280C00011
- Study Id
- D4280C00011
- ClinicalTrials.gov ID
- NCT01430910
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
